148 related articles for article (PubMed ID: 12810303)
1. In vivo release and gene expression of plasmid DNA by hydrogels of gelatin with different cationization extents.
Kushibiki T; Tomoshige R; Fukunaka Y; Kakemi M; Tabata Y
J Control Release; 2003 Jun; 90(2):207-16. PubMed ID: 12810303
[TBL] [Abstract][Full Text] [Related]
2. Controlled release of plasmid DNA from hydrogels prepared from gelatin cationized by different amine compounds.
Kushibiki T; Tomoshige R; Iwanaga K; Kakemi M; Tabata Y
J Control Release; 2006 May; 112(2):249-56. PubMed ID: 16545479
[TBL] [Abstract][Full Text] [Related]
3. Controlled release of plasmid DNA from cationized gelatin hydrogels based on hydrogel degradation.
Fukunaka Y; Iwanaga K; Morimoto K; Kakemi M; Tabata Y
J Control Release; 2002 Apr; 80(1-3):333-43. PubMed ID: 11943409
[TBL] [Abstract][Full Text] [Related]
4. In vivo release of plasmid DNA from composites of oligo(poly(ethylene glycol)fumarate) and cationized gelatin microspheres.
Kasper FK; Kushibiki T; Kimura Y; Mikos AG; Tabata Y
J Control Release; 2005 Oct; 107(3):547-61. PubMed ID: 16139915
[TBL] [Abstract][Full Text] [Related]
5. Preparation of poly(ethylene glycol)-introduced cationized gelatin as a non-viral gene carrier.
Kushibiki T; Tabata Y
J Biomater Sci Polym Ed; 2005; 16(11):1447-61. PubMed ID: 16370244
[TBL] [Abstract][Full Text] [Related]
6. In vitro transfection of plasmid DNA by cationized gelatin prepared from different amine compounds.
Kushibiki T; Tomoshige R; Iwanaga K; Kakemi M; Tabata Y
J Biomater Sci Polym Ed; 2006; 17(6):645-58. PubMed ID: 16892726
[TBL] [Abstract][Full Text] [Related]
7. Enhanced anti-fibrotic activity of plasmid DNA expressing small interference RNA for TGF-beta type II receptor for a mouse model of obstructive nephropathy by cationized gelatin prepared from different amine compounds.
Kushibiki T; Nagata-Nakajima N; Sugai M; Shimizu A; Tabata Y
J Control Release; 2006 Feb; 110(3):610-7. PubMed ID: 16378654
[TBL] [Abstract][Full Text] [Related]
8. Preparation of gelatin hydrogels incorporating low-molecular-weight heparin for anti-fibrotic therapy.
Saito T; Tabata Y
Acta Biomater; 2012 Feb; 8(2):646-52. PubMed ID: 22079782
[TBL] [Abstract][Full Text] [Related]
9. Biodegradation of hydrogel carrier incorporating fibroblast growth factor.
Tabata Y; Nagano A; Ikada Y
Tissue Eng; 1999 Apr; 5(2):127-38. PubMed ID: 10358220
[TBL] [Abstract][Full Text] [Related]
10. Gene transduction into aortic wall using plasmid-loaded cationized gelatin hydrogel-coated polyester stent graft.
Zhong H; Matsui O; Xu K; Ogi T; Sanada J; Okamoto Y; Tabata Y; Takuwa Y
J Vasc Surg; 2009 Dec; 50(6):1433-43. PubMed ID: 19782523
[TBL] [Abstract][Full Text] [Related]
11. Preparation of Biodegradable Gelatin Nanospheres with a Narrow Size Distribution for Carrier of Cellular Internalization of Plasmid DNA.
Doi N; Jo J; Tabata Y
J Biomater Sci Polym Ed; 2012; 23(8):991-1004. PubMed ID: 21477460
[TBL] [Abstract][Full Text] [Related]
12. Preparation of gelatin hydrogels incorporating small interfering RNA for the controlled release.
Saito T; Tabata Y
J Drug Target; 2012 Dec; 20(10):864-72. PubMed ID: 23009281
[TBL] [Abstract][Full Text] [Related]
13. Controlled release of hepatocyte growth factor from gelatin hydrogels based on hydrogel degradation.
Ozeki M; Ishii T; Hirano Y; Tabata Y
J Drug Target; 2001; 9(6):461-71. PubMed ID: 11822818
[TBL] [Abstract][Full Text] [Related]
14. Cationized gelatin hydrogels mixed with plasmid DNA induce stronger and more sustained gene expression than atelocollagen at calvarial bone defects in vivo.
Komatsu K; Shibata T; Shimada A; Ideno H; Nakashima K; Tabata Y; Nifuji A
J Biomater Sci Polym Ed; 2016; 27(5):419-30. PubMed ID: 26848778
[TBL] [Abstract][Full Text] [Related]
15. Ultrasound enhancement of in vitro transfection of plasmid DNA by a cationized gelatin.
Hosseinkhani H; Aoyama T; Ogawa O; Tabata Y
J Drug Target; 2002 May; 10(3):193-204. PubMed ID: 12075820
[TBL] [Abstract][Full Text] [Related]
16. Ultrasound enhances in vivo tumor expression of plasmid DNA by PEG-introduced cationized dextran.
Hosseinkhani H; Tabata Y
J Control Release; 2005 Nov; 108(2-3):540-56. PubMed ID: 16219383
[TBL] [Abstract][Full Text] [Related]
17. Vascularization effect of basic fibroblast growth factor released from gelatin hydrogels with different biodegradabilities.
Tabata Y; Ikada Y
Biomaterials; 1999 Nov; 20(22):2169-75. PubMed ID: 10555085
[TBL] [Abstract][Full Text] [Related]
18. In vivo anti-tumor effect through the controlled release of cisplatin from biodegradable gelatin hydrogel.
Konishi M; Tabata Y; Kariya M; Suzuki A; Mandai M; Nanbu K; Takakura K; Fujii S
J Control Release; 2003 Oct; 92(3):301-13. PubMed ID: 14568411
[TBL] [Abstract][Full Text] [Related]
19. Bone regeneration by transforming growth factor beta1 released from a biodegradable hydrogel.
Yamamoto M; Tabata Y; Hong L; Miyamoto S; Hashimoto N; Ikada Y
J Control Release; 2000 Feb; 64(1-3):133-42. PubMed ID: 10640652
[TBL] [Abstract][Full Text] [Related]
20. Enhanced expression of plasmid DNA-cationized gelatin complex by ultrasound in murine muscle.
Aoyama T; Hosseinkhani H; Yamamoto S; Ogawa O; Tabata Y
J Control Release; 2002 Apr; 80(1-3):345-56. PubMed ID: 11943410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
